INTRODUCTION.
IA 3 is a 68 amino acid yeast protein that inhibits yeast proteinase A (YprA) with a K i of about 1 nM. No other aspartic proteinase has been found to be inhibited by IA 3 , and at least 15 aspartic proteinases related to YprA cleave IA 3 as a substrate [1, 2] . An X-RAY crystal structure has shown that the first 34 amino acids of IA 3 binds to YprA as an α-helix [3] . IA 3 does not crystallize in the absence of YprA, and we have now found by NMR and CD that IA 3 is unfolded in solution and undergoes a large structural transition upon binding to YprA. 3 were then added to natural abundance YprA and were titrated with YprA and TFE (trifluoroethanol). Circular dichroism (CD) was also used to monitor changes of IA 3 upon addition of TFE. The inhibition constants (K i ) of IA 3 for YprA were determined as a function of temperature for van't Hoff analysis.
METHODS.

RESULTS.
The chemical shifts of free IA 3 were found to be essentially random-coil values. The CD spectrum of IA 3 was characteristic of a random-coil peptide but changed to α-helix upon addition of approximately 30% TFE. The 15 N-HSQC NMR spectra of IA 3 were characteristic of random-coil structure, but the addition of YprA produced a large structural transition in IA 3 (Fig.  1) . The IA 3 samples used for NMR analysis were active and inhibited YprA with a K i of about 2 nM.
H-
15 N heteronuclear NOEs at 600 MHz of free IA 3 were very small or negative, consistent with the expected dynamics of an unfolded protein. A van't Hoff analysis of the temperaturedependence of the Ki of IA 3 for YprA was nonlinear, suggesting a rather complex coupled equilibria of protein folding and inhibition (Fig. 2) . 
= 76 ± 9 kJ/mol and ∆Cp = -4.6 ± 1.2 kJ/mol-K, at a reference temperature T 0 = 25°C. These data and the simple model therefore suggest that IA 3 binds endothermically to YprA at room temperature, but with an overall heat capacity change that decreases with temperature, so that binding becomes exothermic near 40°C. The entropy of binding is not well determined in this type of analysis. However, this standard two-state thermodynamic model may be regarded as oversimplifying the actual binding, which entails both protein folding and ligand binding. DISCUSSION. IA 3 has a large structural transition upon binding to YprA. NMR and CD data have shown that the fully active IA 3 is unstructured in solution, and X-RAY data have shown that the N-terminal half of IA 3 forms a near-perfect α-helix in complex with YprA. The precise mechanism of inhibition of YprA by IA 3 is still unclear. Specifically, we do not yet know whether YprA selects very small (currently undetectable) amounts of α-helical IA 3 for binding or whether YprA provides a template upon which IA 3 folds into a helix. More thermodynamic measurements are needed, but the van't Hoff analysis suggests that the folding and inhibition steps are coupled together. To sort out the steps of folding and binding, we are currently designing major modifications to IA 3 to force it to become an α-helix in solution.
